title: Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
authors.affiliation: Department of Urology, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute for Urologic Research, Berlin, Germany. Electronic address: carsten.stephan@charite.de.
authors.forename: Carsten
authors.initials: C
authors.lastname: Stephan
authors.affiliation: Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Germany.
authors.forename: Henning
authors.initials: H
authors.lastname: Cammann
authors.affiliation: Department of Urology, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute for Urologic Research, Berlin, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Jung
mesh_terms: D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms; D018570:Risk Assessment